Skip to content

Gut Microbial Changes After Periodontal Treatment

Evaluation of Salivary and Intestinal Microbiological Response in Patients With Stage III-IV Periodontitis After Non-surgical Periodontal Therapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04982302
Enrollment
94
Registered
2021-07-29
Start date
2021-05-01
Completion date
2023-02-01
Last updated
2023-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysbiosis, Intestinal Disease, Periodontitis

Brief summary

Periodontitis is a chronic inflammatory disease of the tooth supporting structures induced by a dysbiosis in the oral and subgingival microenvironment of susceptible patients. The long-term swallowing of high doses of periodontal pathogenic microorganisms could induce a dysbiosis of the intestinal microbiota, favouring the establishment of an 'inflamed' microbiome in terms of composition and/or function. The present project is aimed at a better understanding of the etiopathogenetic correlation between periodontitis and intestinal dysbiosis, and aims to explore the hypothesis that non-surgical periodontal treatment may reduce bacterial alpha diversity in stool samples. Fifty patients affected by stage III-IV periodontitis will be recruited, and treated by means of full-mouth scaling and root planing. Salivary and stool samples, together with a complete periodontal charting and a food diary will be collected and compared at baseline and 3 months after treatment. Age, gender and BMI-matched healthy individuals will be recruited as controls.

Interventions

PROCEDURENon-surgical periodontal treatment

Subgingival instrumentation with ultrasonic devices and curettes of all periodontal pockets

Sponsors

University of Turin, Italy
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* periodontitis Stage III or IV * BMI between 20 and 29 kg/m2 * free diet * presence of at least 20 teeth

Exclusion criteria

* systemic diseases (including diabetes, thyroid, liver, or kidney diseases) * dietary allergies * use of antibiotics or probiotics during the previous 30 days * pregnancy or breast feeding

Design outcomes

Primary

MeasureTime frameDescription
Changes in microbiome alpha diversity measured from stool samples at 3 months[Time Frame: Baseline and 90 days]Taxonomic and functional variation of gut bacteria after treatment

Secondary

MeasureTime frameDescription
Changes in microbiome alpha diversity measured from saliva samples at 3 months[Time Frame: Baseline and 90 days]Taxonomic and functional variation of salivary bacteria after treatment
Changes in mean clinical attachment level (CAL) at 3 months[Time Frame: Baseline and 90 days]Variation in CAL after therapy assessed using a millimetre marked manual periodontal probe at 6 sites per tooth element
Changes in periodontal pocket depth (PPD) at 3 months[Time Frame: Baseline and 90 days]Variation in PPD after therapy assessed using a millimetre marked manual periodontal probe at 6 sites per tooth element
Changes in full mouth bleeding score (FMBS) at 3 months[Time Frame: Baseline and 90 days]Variation in the percentage of bleeding sites after therapy assessed by gentle probing at 6 sites per tooth element

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026